Pediatrix Medical Group (NYSE:MD) Rating Lowered to "Buy" at Wall Street Zen

Key Points

• Pediatrix Medical Group (NYSE:MD) has been downgraded from a "strong-buy" to a "buy" rating by Wall Street Zen, impacting investor sentiment.
• The stock price target from UBS Group has increased to $16.50, while Zacks Research raised their rating to "strong-buy," indicating mixed analyst opinions.
• Pediatrix reported a 53% increase in earnings per share compared to the previous year, although revenue decreased by 7.1%, highlighting challenges despite profitability.

Wall Street Zen lowered shares of Pediatrix Medical Group (NYSE:MD - Free Report) from a strong-buy rating to a buy rating in a report published on Saturday morning.

Several other research firms have also recently commented on MD. Zacks Research raised Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. UBS Group increased their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Finally, Leerink Partners increased their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, Pediatrix Medical Group has a consensus rating of "Moderate Buy" and an average target price of $16.79.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock traded up $0.42 during trading hours on Friday, hitting $16.60. The stock had a trading volume of 754,117 shares, compared to its average volume of 707,547. The company has a 50-day moving average of $14.98 and a two-hundred day moving average of $14.22. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The company has a market cap of $1.45 billion, a PE ratio of 12.87 and a beta of 1.30. Pediatrix Medical Group has a fifty-two week low of $10.39 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company's revenue for the quarter was down 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.34 EPS. On average, equities research analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of large investors have recently bought and sold shares of the business. California State Teachers Retirement System boosted its position in shares of Pediatrix Medical Group by 0.9% in the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after purchasing an additional 752 shares during the last quarter. AlphaQuest LLC raised its stake in Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock worth $85,000 after buying an additional 811 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in Pediatrix Medical Group by 8.7% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company's stock worth $171,000 after buying an additional 950 shares during the period. SummerHaven Investment Management LLC raised its stake in Pediatrix Medical Group by 0.9% during the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after buying an additional 1,028 shares during the period. Finally, New York State Common Retirement Fund raised its stake in Pediatrix Medical Group by 1.7% during the 2nd quarter. New York State Common Retirement Fund now owns 62,245 shares of the company's stock worth $893,000 after buying an additional 1,034 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.